Vir Biotechnology (VIR) Gross Margin (2020 - 2025)
Vir Biotechnology recorded quarterly Gross Margin of 99.09% in Q2 2025, down 0.91% quarter-over-quarter from 100.0% in Q1 2025, and up 78.0% year-over-year from 55.67% in Q2 2024.
Vir Biotechnology's Gross Margin history runs 6 years deep, the most recent figure standing at 99.09% for Q2 2025.
- In Q2 2025, Gross Margin rose 78.0% year-over-year to 99.09%; the TTM figure through Jun 2025 stood at 96.08% (down 264.0% YoY), while the FY2025 annual figure was 99.96%, up 110.0% from the prior year.
- Gross Margin came in at 99.09% for Q2 2025 at Vir Biotechnology, down from 100.0% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q1 2021 to a low of 31.28% in Q2 2022.
- A 5-year average of 92.81% and a median of 97.44% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin slumped 6804 bps in 2022 and surged 6814 bps in 2023, its largest moves.
- Vir Biotechnology's Gross Margin stood at 93.0% in 2021, then dropped by 6 bps to 87.86% in 2022, then advanced by 8 bps to 95.25% in 2023, then decreased by 1 bps to 94.47% in 2024, then advanced by 5 bps to 99.09% in 2025.
- According to Business Quant data, Gross Margin over the past three periods registered 99.09%, 100.0%, and 94.47% for Q2 2025, Q1 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 99.09% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | 94.47% |
| Sep 30, 2024 | 97.90% |
| Jun 30, 2024 | 98.31% |
| Mar 31, 2024 | 99.89% |
| Dec 31, 2023 | 95.25% |
| Sep 30, 2023 | 98.56% |
| Jun 30, 2023 | 99.42% |
| Mar 31, 2023 | 96.97% |
| Dec 31, 2022 | 87.86% |
| Sep 30, 2022 | 94.06% |
| Jun 30, 2022 | 31.28% |
| Mar 31, 2022 | 92.69% |
| Dec 31, 2021 | 93.00% |
| Sep 30, 2021 | 92.44% |
| Jun 30, 2021 | 99.32% |
| Mar 31, 2021 | 100.00% |
| Dec 31, 2020 | 100.00% |
| Sep 30, 2020 | 100.00% |
| Jun 30, 2020 | 100.00% |